Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01117064 · ClinicalTrials.gov registry record · Phase 1
Neuromodulation Therapy Device for the Treatment of Sleep Apnea
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT01117064: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT01117064 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01117064, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
We are looking to test a novel device in the treatment of Obstructive Sleep Apnea (OSA). Rather than using positive pressure to open the airways, we are testing a device that delivers an auditory tone to affect neuromodulation. We will test its efficacy in treating OSA while minimizing sleep disturbance. As this device is much less cumbersome to wear, we hope this therapy device will also improve compliance with treatment.
Interventions
- DEVICE Neuromodulation Therapy Device (NMTD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01117064
The ClinicalTrials.gov registry entry for NCT01117064 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Neuromodulation Therapy Device (NMTD) is the first listed.
NCT01117064 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01117064 about?
NCT01117064 is a clinical study titled "Neuromodulation Therapy Device for the Treatment of Sleep Apnea". We are looking to test a novel device in the treatment of Obstructive Sleep Apnea (OSA). Rather than using positive pressure to open the airways, we are testing a device that delivers an auditory tone to affect neuromodulation. We will test its efficacy in treating OSA while minimizing sleep disturb...
What is the current status of trial NCT01117064?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2010-02. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01117064?
The interventions under investigation include: Neuromodulation Therapy Device (NMTD) (DEVICE).
Who is sponsoring clinical trial NCT01117064?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.